A prospective study on the histological evaluation of type 1 autoimmune pancreatitis using endoscopic ultrasound‐guided fine needle biopsy with a 19‐gauge Franseen needle

Takuya Ishikawa,Kentaro Yamao,Yasuyuki Mizutani,Tadashi Iida,Kota Uetsuki,Yoshie Shimoyama,Masanao Nakamura,Kazuhiro Furukawa,Takeshi Yamamura,Hiroki Kawashima
DOI: https://doi.org/10.1002/jhbp.1438
2024-05-09
Journal of Hepato-Biliary-Pancreatic Sciences
Abstract:Background/Purpose To assess the diagnostic efficacy and safety of endoscopic ultrasound‐guided fine needle biopsy (EUS‐FNB) using a 19‐gauge Franseen needle for autoimmune pancreatitis (AIP). Methods Twenty patients suspected of having type 1 AIP were prospectively enrolled and underwent EUS‐FNB with a 19‐gauge Franseen needle. Their data were compared with those of historical controls: a total of 29 type 1 AIP patients had EUS‐FNB with a 22‐gauge Franseen needle. Results Specimens suitable for histological evaluation were obtained from 19 of the 20 patients (95%), and the median total tissue area was 11.9 mm2. The histological diagnosis rate of AIP was 65% (95% CI: 43.2%–82%). Adverse events were observed in three patients (15%), and a switch to 22‐gauge needles occurred during transduodenal puncture in two patients. Compared to those punctured with 22‐gauge needles, patients punctured with 19‐gauge needles had greater prevalence of each characteristic feature of lymphoplasmacytic sclerosing pancreatitis, but the difference was not statistically significant. Conclusions EUS‐FNB using a 19‐gauge Franseen needle demonstrated favorable performance for the histological diagnosis of AIP and allowed for large tissue samples, potentially facilitating pathological diagnosis. However, during transduodenal puncture, maneuverability is reduced; therefore, the needle may need to be selected according to the puncture site.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?